Zymeworks Inc. - stock earnings
ZYME Upcoming estimated earnings
| Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
|---|---|---|---|---|
| May 2, 2024 AfterMarket | -0.42 / -0.30 | - | 10.0 million / 17.8 million | - |
ZYME Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -14.5 million USD | 16.9 million USD |
| 2023Q3 | -28.7 million USD | 16.5 million USD |
| 2023Q2 | -51.2 million USD | 7.0 million USD |
| 2023Q1 | -24.4 million USD | 35.6 million USD |
| 2022Q4 | 309.4 million USD | 402.5 million USD |
| 2022Q3 | -47.8 million USD | 2.6 million USD |
| 2022Q2 | -64.6 million USD | 5.4 million USD |
| 2022Q1 | -72.6 million USD | 1.9 million USD |
| 2021Q4 | -39.2 million USD | 19.9 million USD |
| 2021Q3 | -60.6 million USD | 4.4 million USD |
| 2021Q2 | -67.5 million USD | 1.8 million USD |
| 2021Q1 | -44.6 million USD | 644000 USD |
| 2020Q4 | -37.9 million USD | 15.7 million USD |
| 2020Q3 | -72.6 million USD | 2.6 million USD |
| 2020Q2 | -39.0 million USD | 12.4 million USD |
| 2020Q1 | -31.1 million USD | 8.3 million USD |
| 2019Q4 | -72.2 million USD | 1.9 million USD |
| 2019Q3 | -30.5 million USD | 7.9 million USD |
| 2019Q2 | -29.1 million USD | 7.9 million USD |
| 2019Q1 | -13.6 million USD | 11.9 million USD |
| 2018Q4 | 9.3 million USD | 28.9 million USD |
| 2018Q3 | -18.8 million USD | 2.1 million USD |
| 2018Q2 | -5.9 million USD | 22.0 million USD |
| 2018Q1 | -21.2 million USD | 40000 USD |
| 2017Q4 | 32.7 million USD | 50.1 million USD |
| 2017Q3 | -16.2 million USD | 119000 USD |
| 2017Q2 | -11.0 million USD | 1.3 million USD |
| 2017Q1 | -15.9 million USD | 230000 USD |
| 2016Q4 | -11.3 million USD | 2.2 million USD |
| 2016Q3 | -12.4 million USD | 2.2 million USD |
| 2016Q2 | -7.4 million USD | 6.3 million USD |
| 2016Q1 | -2.7 million USD | 262000 USD |
| 2015Q4 | -7.9 million USD | 1.4 million USD |
| 2015Q3 | ? USD | 340000 USD |
| 2015Q2 | ? USD | 4.0 million USD |
| 2015Q1 | ? USD | 3.9 million USD |
ZYME Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -118.7 million USD | 76.0 million USD |
| 2022 | 124.3 million USD | 412.5 million USD |
| 2021 | -211.8 million USD | 26.7 million USD |
| 2020 | -180.6 million USD | 39.0 million USD |
| 2019 | -145.4 million USD | 29.5 million USD |
| 2018 | -36.6 million USD | 53.0 million USD |
| 2017 | -10.4 million USD | 51.8 million USD |
| 2016 | -33.8 million USD | 11.0 million USD |
| 2015 | -19.2 million USD | 9.7 million USD |
| 2014 | -12.9 million USD | 1.7 million USD |
ZYME
Price: $9.20
52 week price:
Earnings Per Share: -1.72 USD
P/E Ratio: 3.45
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 105946
Ebitda: -15.5 millionMarket Capitalization: 652.8 million